Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board shared a post on LinkedIn:
”Iron deficiency can hide beta-thalassaemia trait.
This creates a real problem in antenatal screening.
Here’s why: Low iron falsely lowers HbA₂ levels. The result? A pregnant woman with beta-thalassaemia trait can get a false-negative result. And that means missed genetic counselling.
The solution is simple. Don’t wait.
Here’s what every obstetric team needs to know:
Screen at booking, even if iron deficiency is suspected. Don’t delay haemoglobin variant analysis.
Borderline HbA₂ (3.0-3.4%) with low ferritin (<30 µg/L)? Start iron therapy and retest after 8-12 weeks.
Test the partner in parallel if the maternal result is positive or borderline. Time matters.
When results remain unclear, escalate to DNA testing. Don’t guess.
The UK NHS Sickle Cell and Thalassaemia Screening Programme is clear on this: Timing keeps options open for couples who may be at risk of having a child with thalassaemia major.
Are you seeing borderline HbA₂ results in your antenatal patients? How do you handle them?”

More posts from Dr Abdul Mannan on Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria